PATENT CLAIM ANALYSIS

Application Number: 16060714
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "274000"]

Abstract:
The present invention provides a modulator of Kv3.1 and/or Kv3.2 and/or Kv3.3 channels for use in the prophylaxis or treatment of pain. Modulators for use in the prophylaxis or treatment of pain include compounds of formula (I) or a pharmaceutically acceptable salt and/or solvate thereof and/or derivative thereof: (I).

Claim (Index 8):
The method or according to claim  1 , wherein the pain is selected from acute pain, chronic pain, nociceptive pain (such as somatic pain or visceral pain), neuropathic pain (such as central neuropathic pain, peripheral neuropathic pain, diabetic neuropathy, post-herpetic neuralgia, spinal cord injury pain, phantom limb (post-amputation) pain or post-stroke central pain, or wherein the neuropathic pain is due to trauma, chemotherapy or heavy metal exposure), inflammatory pain (such as inflammatory pain is caused by appendicitis, rheumatoid arthritis, inflammatory bowel disease or herpes zoster) and miscellaneous pain (such as cancer pain, migraine or other primary headaches, or wide-spread pain of the fibromyalgia type).

Metadata:
- Claim Count in Document: 54.0
- Percentile: 94.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14403011', '15730559', '14361510', '15208329', '14403048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8302803464814669
- 35 USC 102 Novelty (BERT): 0.5645217366697839
- Combined Prediction Score: 0.8037044855002986
- Mean Citation Score: 527.578932
- Max Citation Score: 633.7182
- Similarity Product: 297.8907461534143

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test